First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX Plus¹²⁵IUdR

Abstract

(125)IUdR treatment proved to be feasible without acute neurological toxicity and seemed to have produced a biological response. This attempt provides the basis for designing prospective clinical trials.